History below at link.
But basically...PET/low dose non contrast CT suggests:
Much insulted liver as free from activity as 2/7/11. Yayy!!
But....
Stubborn left lower lobe lung met (down to one) seems to be going strong. Although I have some questions about the measurement accuracy (always do) this may be a too close to home rendition of my oft mentioned suspicions that multiple met locations can have very different behaviors.
Hard to argue with the contiunued great results in the liver...the issue that almost swept a jaundiced, confused mom away in '08.
And a unique weekly Zometa approach seems to have removed the C4 spinal met from the equation...hopefully helping the larger picture somehow too.
But damn if that
big lung met isn't turning out to be the focal point.
So....biopsy of some sort to discern the difference? Seems unlikely enough could be had for chemosensitivity testing.
It's probably too big a met to recruit someone to do local therapy like ablation etc...especially with systemic mets.
Roll the dice and add a random agent to the regimen? She's on Tamoxifen, low dose xeloda (3), Cytoxan, Tykerb (4), metformin and supplements as listed. Maybe add herceptin in case it's a hyper her2 thang?
Oy......
Quote:
6/8/11 PET/CT: Lung mass from 4.1 x 3.4 (or 4.4 x 4.0) to 5.8 x 4.4 cm at maximum axial dimensions. SUV max from 11.6 to 14.7. No mention of extending into chest wall. Relevant to measurement? No other nodules noted.
2 Retroesophogeal lymph nodes insignificant size change, but SUV max from 5.4 to 8.8. Significant or due to more FDG and slightly longer wait before scan??
No uptake in liver!
No uptake in C4 (spine)!
Obviously a difference in behavior between liver and lung.
|
Threaded Mode